According to the Chinese pharmaceutical company, monkeys were “largely protected” from the infection during a trial on animals with a vaccine for the Novel Corona virus.
According to a report published by the French news agency AFP in the Dawn newspaper, there are more than 190,000 people around the world with Corona Voice and various countries are in the race to develop a vaccine against this virus.
A company called Cyanobiotics said it injected two different doses of the vaccine into eight monkeys belonging to a species of monkey that was not at risk of extinction.
Three weeks later, they were exposed to the virus but did not become infected.
The company said in a statement that all monkeys were “largely protected from SARS-CoV-2 infection”.
According to the company’s assessment, the four monkeys were given high doses of the vaccine and showed no “symptoms” in their lungs until seven days after the virus entered their bodies.
The company said that the remaining four monkeys, which were given low doses of the vaccine, tested positive for the virus after injecting the virus, but it recovered automatically.
In contrast, the four monkeys that were not vaccinated became seriously ill with the virus and developed pneumonia.
Syvik published the results of his trials online three days after the trials began on humans, but the results will be reviewed by the international scientific community.
This vaccine, like other vaccines, helps the body develop immunity against the disease by inactivating the corona virus.
A company spokesman said the tests showed “good performance” and the company was confident of the vaccine’s ability.
Research has shown that several strains of the corona virus have emerged in research that show the virus is slowly changing its shape, making it more difficult to develop a possible vaccine.